These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Phagocytosis by human monocytes of red cells sensitized with monoclonal IgG1 and IgG3 anti-D. Hadley AG; Kumpel BM Vox Sang; 1989; 57(2):150-1. PubMed ID: 2506695 [No Abstract] [Full Text] [Related]
25. Section 1B: Rh flow cytometry. Coordinator's report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination. Flegel WA; Curin-Serbec V; Delamaire M; Donvito B; Ikeda H; Jørgensen J; Kumpel B; Le Pennec PY; Písacka M; Tani Y; Uchikawa M; Wendel S; Wagner FF Transfus Clin Biol; 2002 Jan; 9(1):33-42. PubMed ID: 11889898 [TBL] [Abstract][Full Text] [Related]
26. Lymphocyte killer activity in individuals sensitized against antigen-D assessed by direct ADCC lysis of O,Rh-positive erythrocytes. Sándor J; Lajos J; Braun J Vox Sang; 1986; 51(4):310-3. PubMed ID: 3099472 [TBL] [Abstract][Full Text] [Related]
28. [Functional study of 11 monoclonal anti-Rh D IgG antibodies. Attempt to define selection criteria with regard to their use in Rh immunoprophylaxis]. Brossard Y; Gosset M; Feuillet-Fieux MN; Bignozzi C; Dangu C Rev Fr Transfus Immunohematol; 1988 Dec; 31(5):711-24. PubMed ID: 3148993 [No Abstract] [Full Text] [Related]
29. Section 2: Immunochemical, immunohistological and serological analysis of monoclonal antibodies with carbohydrates. Coordinator's report. Le Pendu J; Henry S Transfus Clin Biol; 2002 Jan; 9(1):55-60. PubMed ID: 11889900 [No Abstract] [Full Text] [Related]
30. Recombinant polymeric IgG anti-Rh: a novel strategy for development of direct agglutinating reagents. Montano RF; Penichet ML; Blackall DP; Morrison SL; Chintalacharuvu KR J Immunol Methods; 2009 Jan; 340(1):1-10. PubMed ID: 18848836 [TBL] [Abstract][Full Text] [Related]
31. Immunological characterization of 21 human anti-Rh (D) monoclonal antibodies. Le Pennec PY; Klein MT; Le Besnerais M; Tsikas G; Champomier F; Goossens D; Rouger P Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):115-21. PubMed ID: 3145539 [No Abstract] [Full Text] [Related]
32. More on the R0 Har antigenic complex. Case J Transfusion; 1996; 36(11-12):1034-5. PubMed ID: 8937417 [No Abstract] [Full Text] [Related]
34. Monoclonal antibodies to red cell alloantigens with particular reference to anti-D. Hughes-Jones NC; Parsons SF Transfus Med Rev; 1992 Jul; 6(3):191-200. PubMed ID: 1498464 [No Abstract] [Full Text] [Related]
35. Introduction to in vivo targeting. Chiarantini L; Droleskey RE; DeLoach JR Adv Exp Med Biol; 1992; 326():269-77. PubMed ID: 1295315 [No Abstract] [Full Text] [Related]
37. Development and evaluation of a competitive radioimmunoassay using monoclonal antibodies against Rh D for determining anti-D potency of clinical grade immunoglobulin preparations. Thorpe SJ; Heath AB Transfus Med; 1995 Jun; 5(2):97-103. PubMed ID: 7655583 [TBL] [Abstract][Full Text] [Related]
38. Weak D type 1.1 exemplifies another complexity in weak D genotyping. Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206 [TBL] [Abstract][Full Text] [Related]
39. Hemagglutination and the closest distance of approach of normal, neuraminidase- and papain-treated erythrocytes. van Oss CJ; Absolom DR Vox Sang; 1984; 47(3):250-6. PubMed ID: 6431697 [TBL] [Abstract][Full Text] [Related]
40. Critical review of protease-treated red cell tests for the detection of irregular blood group antibodies during pregnancy. Jemmolo G; Malferrari F; Tazzari PL; Conte R Vox Sang; 1995; 69(2):144. PubMed ID: 8585199 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]